Showing results (41-50 of 392) with videos related to

Sort By:
Pageof 40
Nature Reviews. Cancer|December 4, 2009
From pathogenesis to treatment of chronic lymphocytic leukaemiaThorsten Zenz, Daniel Mertens, Ralf Küppers, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
Advanced Biology|August 3, 2023
Aging Associates with Cilium Elongation and Dysfunction in Kidney and PancreasFabian Adametz, Annika Müller, Stephan Stilgenbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2017
Venetoclax in Patients with Previously Treated Chronic Lymphocytic LeukemiaAndrew W Roberts, Stephan Stilgenbauer, John F Seymour, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.
International Journal of Cancer|June 10, 2010
Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLLClaudia Philipp, Jennifer Edelmann, Andreas Bühler, et al.
Scientific Data|May 3, 2020
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyDeyan Yordanov Yosifov, Johannes Bloehdorn, Hartmut Döhner, et al.
Leukemia & Lymphoma|August 20, 2024
The NOTCH1 and miR-34a signaling network is affected by <i>TP53</i> alterations in CLLAlena Sophie Ehrmann, Alex Zadro, Eugen Tausch, et al.
Blood|May 16, 2002
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemiaDaniel Mertens, Stephan Wolf, Petra Schroeter, et al.
Pageof 40